Medicover AB engages in the provision of invitro diagnostics and healthcare services. The company is headquartered in Stockholm, Stockholm and currently employs 49,000 full-time employees. The company went IPO on 2017-05-23. The company offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The firm offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The firm focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Mr. John Stubbington est le Chief Executive Officer de Medicover AB (publ), il a rejoint l'entreprise depuis 2025.
Quelle est la performance du prix de l'action Medicover AB ?
Le prix actuel de Medicover AB est de $16.55, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Medicover AB (publ) ?
Medicover AB (publ) appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Medicover AB (publ) ?
La capitalisation boursière actuelle de Medicover AB (publ) est de $1.2B
Est-ce que Medicover AB (publ) est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 8 analystes ont établi des notations d'analystes pour Medicover AB (publ), y compris 2 achat fort, 3 achat, 4 maintien, 0 vente et 2 vente forte